Silencing human cancer: Identification and uses of microRNAs

Recent Patents on Anti-Cancer Drug Discovery

Volumn 6, Issue 1, 2011, Pages 94-105

  Nicolas, Francisco E ^a   Lopez Gomollon, Sara ^a   Lopez Martinez, Alfonso F ^b   Dalmay, Tamas ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b Bananalink   (United Kingdom)

Author keywords

Cancer; Cancer diagnosis; Cancer therapy; Gene therapy; MicroRNA; MiRNA; MiRNA inhibitor; MiRNA mimic; MiRNA target; Patent; RNA interference; RNA silencing

Indexed keywords

ANTI MIRNA OLIGONUCLEOTIDE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; HEAT SHOCK PROTEIN 90 INHIBITOR; MICRORNA; MIR 101; MIR 16; RETINOIC ACID; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER GENE THERAPY; COMPUTER MODEL; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG HALF LIFE; DRUG STRUCTURE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ALGORITHM; HUMAN; HUMAN GENOME; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL COMPUTING; NONHUMAN; ONCOGENE; PATENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RNA ANALYSIS; RNA HYBRIDIZATION; RNA INTERFERENCE; RNA PURIFICATION; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENE THERAPY; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 78650927296     PISSN: 15748928     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489211793980033     Document Type: Article

References (141)

1. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 2008; 9: 102-14
2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-33
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-54
4. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403: 901-6
5. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-11
6. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97
7. Bartel B, Bartel DP. MicroRNAs: At the root of plant development? Plant Physiol 2003; 132: 709-17
8. Basyuk E, Suavet F, Doglio A, Bordonne R, Bertrand E. Human let-7 stem-loop precursors harbor features of RNase III cleavage products. Nucleic Acids Res 2003; 31: 6593-7
9. Baulcombe D. RNA silencing in plants. Nature 2004; 431: 356-63
10. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: Stepwise processing and subcellular localization. EMBO J 2002; 21: 4663-70
11. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432: 231-5
12. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235-40
13. Landthaler M, Yalcin A, Tuschl T. The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 2004; 14: 2162-7
14. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-9
15. Zeng Y, Cullen BR. Sequence requirements for micro RNA processing and function in human cells. RNA 2003; 9: 112-23
16. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303: 95-8
17. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003; 17: 3011-6
18. Grishok A, Sharp PA. Negative regulation of nuclear divisions in Caenorhabditis elegans by retinoblastoma and RNA interferencerelated genes. Proc Natl Acad Sci USA 2005; 102: 17360-5
19. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002; 297: 2056-60
20. Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD. A protein sensor for siRNA asymmetry. Science 2004; 306: 1377-80
21. Leuschner PJ, Ameres SL, Kueng S, Martinez J. Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep 2006; 7: 314-20
22. Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 2005; 123: 607-20
23. Rand TA, Petersen S, Du F, Wang X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 2005; 123: 621-9
24. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001; 293: 1146-50
25. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002; 110: 563-74
26. Caudy AA, Ketting RF, Hammond SM, Denli AM, Bathoorn AM, Tops BB, et al. A micrococcal nuclease homologue in RNAi effector complexes. Nature 2003; 425: 411-4
27. Caudy AA, Myers M, Hannon GJ, Hammond SM. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 2002; 16: 2491-6
28. Ishizuka A, Siomi MC, Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev 2002; 16: 2497-508
29. Khvorova A, Reynolds A, Jayasena S.D. Functional siRNAs siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209-16
30. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199-208
31. Seggerson K, Tang L, Moss EG. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol 2002; 243: 215-25
32. Humphreys DT, Westman BJ, Martin DI, Preiss T. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 2005; 102: 16961-6
33. Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T, et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 2007; 317: 1764-7
34. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005; 309: 1573-6
35. Wang B, Love TM, Call ME, Doench JG, Novina CD. Recapitulation of short RNA-directed translational gene silencing in vitro. Mol Cell 2006; 22: 553-60
36. Sen GL, Blau HM. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 2005; 7: 633-6
37. Rossi JJ. RNAi and the P-body connection. Nat Cell Biol 2005; 7: 643-4
38. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005; 7: 719-23
39. Coller J, Parker R. Eukaryotic mRNA decapping. Annu Rev Biochem 2004; 73: 861-90
40. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005; 122: 553-63
41. Eulalio A, Huntzinger E, Izaurralde E. GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nat Struct Mol Biol 2008; 15: 346-53
42. Parker JS, Roe SM, Barford D. Molecular mechanism of target RNA transcript recognition by Argonaute-guide complexes. Cold Spring Harb Symp Quant Biol 2006; 71: 45-50
43. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. Short RNAs repress translation after initiation in mammalian cells. Mol Cell 2006; 21: 533-42
44. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-50
45. Dalmay T. MicroRNAs and cancer. J Intern Med 2008; 263: 366-75
46. Iorio MV, Croce CM. MicroRNAs in cancer: Small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-56
47. Godlewski J, Newton HB, Chiocca EA, Lawler SE. MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ 2009 (in press)
48. Chen C, Ridzon D, Lee CT, Blake J, Sun Y, Strauss WM. Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets. Mamm Genome. Mamm Genome 2007; 18: 316-27
49. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61
50. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8
51. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-36
52. Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, Guadagnoli M, et al. The inhibition of the highly expressed miR221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE 2008; 3: e4029
53. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008; 26: 462-9
54. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-98
55. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-36
56. Defago MD, Soria EA. Biomarker assessment in nutritional modulation of oxidative stress-induced cancer development by lipid-related bioactive molecules. Recent Pat Anticancer Drug Discov 2010; 5(3): 188-96
57. Bentwich, I., Avniel, A., Karov, M., Aharonov, R. Bladder cancerrelated nucleic acids. US20070259349 (2007)
58. Bentwich, I., Avniel, A., Karov, M., Aharonov, R. Prostate cancerrelated nucleic acids. US20070259352 (2007)
59. Bentwich, I., Avniel, A., Karov, M., Aharonov, R. Lung cancerrelated nucleic acids. US20080182237 (2008)
60. Bentwich, I., Avniel, A., Karov, M., Aharonov, R. Liver cancerrelated nucleic acids. US20070259350 (2007)
61. Mambo, E., Davidson, T.S., LeBourgeois, P. A. Microrna markers for recurrence of colorectal cancer. US20090233297 (2009)
62. Huibregtse, S.B., Labourier, E., Elizondo, L. Micrornas differentially expressed in cervical cancer and uses thereof. US20090186348 (2009)
63. Lancaster, J.M. Micro-RNA profiles associated with endometrial cancer development and response to cisplatin and doxorubicin chemotherapy. US20090291452 (2009)
64. Beaudenon, S., Elizondo, L., Doleshal, M., Brown, D., Labourier, E. MiRNAs differentially expressed in lymph nodes from cancer patients. US20090263803 (2009)
65. Wong, D.T.W., Park, N.J. Micro-RNA profile in human saliva and its uses for detection of oral cancer. US20090317820 (2009)
66. Raponi, M., Dossey, L.E. Process for predicting the prognosis of squamous cell lung cancer. US20090136949 (2009)
67. Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM, et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci USA 2004; 101: 360-5
68. Qin, L.K. Pure miRNA sample preparation method. US20070059739 (2007)
69. Remacle J., du Longueville, F. Detection and quantification of miRNA on microarrays. US20060099619 (2006)
70. Wang, E. Microarray, system, and method for detecting, identifying, and quantitating micro-RNAs. US20080312099 (2008)
71. Finn, A.K., Chen, C. Two colour real time end point quantification of microRNAs. US20060078924 (2009)
72. Tan, R., Chen, C., Guegler, J. Method to quantify siRNAs, miRNAs and polymorphic miRNAs. US20070111226 (2007)
73. Ahlquist, P.G., Sengupta, S., den Boon, J.A., Sugden, B., Newton, M.A. Reagents and methods for miRNA expression analysis and identification of cancer biomarkers. US20090099034 (2009)
74. Allawi, H.T., Lyamichev, V. Detection of nucleic acids. US20080131890 (2008)
75. Han, J., Huntsville A.L. Methods for detecting ncRNA. US20080166707 (2008)
76. Esau, C., Davis, S.E., Bennett, F.C. MicroRNA detection. US20090236225 (2009)
77. Li, X., Jiang, X. High throughput detection of micrornas and use for disease diagnosis. US20090181390 (2009)
78. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010; 20: 589-99
79. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-9
80. Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005; 352: 1667-76
81. Davis E, Caiment F, Tordoir X, Cavaille J, Ferguson-Smith A, Cockett N, et al. RNAimediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol 2005; 15: 743-9
82. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304: 594-6
83. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes. Science 2003; 299: 1540
84. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455: 64-71
85. Huynh, T., Heights, Y., Miranda, K.C., Rigoutsos, I. Novel oligonucleotide compositions and probe sequences useful for detection and analysis of miRNAs and their target miRNAs. US20070154896 (2007)
86. Bartel, D., Lewis, B.P., Jones-Rhoades, M.W., Burge, C.B. Systems and methods for identifying miRNA targets and for altering miRNA and target expression. US20060185027 (2006)
87. Barrero, R.A., Tamura, T., Gojobori, T., Ikeo, K., Imanishi, T. Method for predicting and identifying target mRNAs controlled by functional RNAs and method of using the same. US20090137505 (2009)
88. Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 2006; 3: 881-6
89. Elmen J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36: 1153-62
90. Beitzinger M, Peters L, Zhu JY, Kremmer E, Meister G. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol 2007; 4: 76-84
91. Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 2007; 104: 19291-6
92. Schroth, G.P., Lao, K.Q., Straus, N.A. Id-tag complexes, arrays and methods of use thereof. US20060292586 (2006)
93. Kauppinen, S., Plasterk, R., Wienholds, E., Kloosterman, W. System and method for identification of miRNA target sites and corresponding targeting miRNA sequences. US20070099196 (2007)
94. Brian, T., Chait, DC, Yoshi, O. Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy. US6642059 (2003)
95. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63
96. Vinther J, Hedegaard MM, Gardner PP, Andersen JS, Arctander P. Identification of miRNA targets with stable isotope labeling by amino acids in cell culture. Nucleic Acids Res 2006; 34: e107
97. Leite, J.F., Pope, M., Hajivandi, M., Liang, X. Isotopically-labeled proteome standards. US20070031911 (2007)
98. Lee Y, Vassilakos A, Feng N, Jin H, Wang M, Xiong K, et al. GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors. Int J Oncol 2006; 28: 469-78
99. Nasevicius A, Ekker SC. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 2000; 26: 216-20
100. Stepkowski SM, Qu X, Wang ME, Tian L, Chen W, Wancewicz EV, et al. Inhibition of Craf expression by antisense oligonucleotides extends heart allograft survival in rats. Transplantation 2000; 70: 656-61
101. Watts LM, Manchem VP, Leedom TA, Rivard AL, McKay RA, Bao D, et al. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism. Diabetes 2005; 54: 1846-53
102. Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, Song XZ, et al. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 2005; 42: 362-71
103. Brown, D., Ford, L., Cheng, A., Jarvis, R., Byrom, M., Ovcharenko, D., Deveroe, E., Kenalr, K. Methods and compositions involving miRNA and miRNA inhibitor molecules. US20080050744 (2008)
104. Rasko, J.E., Aung, H.T., Bestwick, R.K., Iversen, P.L. Antisense composition and method for inhibition of miRNA biogenesis. US20080199961 (2008)
105. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-73
106. McSwiggen, J., Chowrira, B., Beigelman, L., Macejak, D., Zinnen, S., Pavco, P., Haeberli, P. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA). US20090023675 (2009)
107. Chen, C., Min, H., Liu, G. Pre-miRNA loop-modulated target regulation US20090004668. (2009)
108. Chinnaiyan, A.M., Lnu, S., Cao, Q. EZH2 cancer markers. US20090012031 (2009)
109. Taleshita, F., Brown, D., Ochiya, T. Compositions and methods related to miR-16 and therapy of prostate cancer. US20090253780 (2009)
110. Voinnet, O., Lecellier, C.H., Saumet, A., Lanotte, M. Identification and use of miRNAs for differentiation myeloid leukemia cells. US20090029932 (2009)
111. Shen, J., Kelnar, K., Shelton, J., Brown, D., Campochiaro, P. Composition and methods related to miRNA modulation of neovascularization or angiogenesis. US20090281167 (2009)
112. Trieu, V., Hwang, L., Desai, N. Enhancement of drug therapy by miRNA US20090280167. (2009)
113. Seibler, J., Schenk, Kuter-Lucks B., Bader M., Kotnik K. ShRNA and siRNA and miRNA expression in a living organism under control of a codon-opimized repressor gene. US20090025097 (2009)
114. Thomann, U., Satnge-Thomann, N. Delivery vectors for short interfering RNA, micro-RNA and antisense RNA. US20050203047 (2005)
115. Alexander E. RNA Interference (RNAi) Patents and human health related applications of RNAi. Recent Pat DNA Gene Seq 2007; 1: 128-33
116. Grinberg D. Recent patents relating to siRNAs and therapeutic strategies for genetic diseases. Recent Pat DNA Gene Seq 2008; 2: 40-3
117. Wang M, Xie H, Mi S, Chen J. Recent patents on the identification and clinical application of microRNAs and target genes. Recent Pat DNA Gene Seq 2007; 1: 116-24
118. Buscail L, Cordelier P. Potential of recombinant SV40-based vectors for gene therapy. Recent Pat DNA Gene Seq 2007; 1: 93-9
119. Goyal AK, Khatri K, Vyas SP. Patents on non-viral mediated gene delivery. Recent Pat DNA Gene Seq 2008; 2: 44-60
120. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-9
121. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753-6
122. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-47
123. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-32
124. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-98
125. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 2005; 102: 19075-80
126. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-91
127. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-70
128. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005; 334: 1351-8
129. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-33
130. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102: 3627-32
131. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-8
132. Stone, S., Gutin, A., Wagner, S., Reid, J. Cancer biomarkers. WO2010080933 (2010)
133. Croce, C. M., Calin, G. A. Compositions and methods for the diagnosis and therapy of Bcl2-associated cancers. US20100184830 (2010)
134. Roth-Chiarello, M. Use of RNA obtained from proteolipid complexes circulating in blood for diagnosis and treatment of tumors. WO2010079118 (2010)
135. Zhang, L. Micro-RNA biomarker in cancer. WO2010083312 (2010)
136. Svanholm-Barrie, C., Delfour, O., Persing, D. H. Methods of detecting cervical cancer. WO2010083464 (2010)
137. Aharonov, R., Rosenfeld, N., Rosenwald, S., Barshack, I. Gene expression signature for classification of cancers. US20100178653 (2010)
138. Rosin-Arbesfeld, R., Sklan, E., Zilberberg, A., David, N. Mir-21 promoter driven targeted cancer therapy. WO2010084488 (2010)
139. Lai, Z., Galvin, J. A. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules. US20100183558 (2010)
140. Chang, L., He, J. Small interference RNA gene therapy. US20107763722 (2010)
141. Pintor-Toro, J. A., Moreno-Mateos, M. A., Valle-Rosado, I. Methods and kits to generate mirna and small RNA-expressing vectors, and its application to develop lentiviral expression libraries. WO2010081842 (2010).